REATA PHARMACEUTICALS INC

Profile

Company Names

REATA PHARMACEUTICALS INC

Addresses

5320 LEGACY DRIVE, PLANO, TX 75024

2801 GATEWAY DRIVE SUITE 150, IRVING, TX 75063

Phone Numbers

972-865-2219
972-865-2201

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$368,949,840.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-06-24 
$50,000,000.00 
$50,000,000.00 
$0.00 
Equity 
3
2010-11-10 
$300,000,000.00 
$300,000,000.00 
$0.00 
Equity 
2
2010-02-15 
$1,972,000.00 
$1,972,000.00 
$0.00 
Equity 
1
2009-09-15 
$16,977,840.00 
$79,333,335.00 
$62,355,495.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
AUDHYA 
EXECUTIVE OFFICER
JAMES 
 
BASS 
DIRECTOR
JAMES 
E. 
BASS 
DIRECTOR
DAWN 
C. 
BIR 
EXECUTIVE OFFICER
CASI 
 
DEYOUNG 
EXECUTIVE OFFICER
CATHERINE 
 
FANNING 
EXECUTIVE OFFICER
ERIC 
 
GROSSMAN 
EXECUTIVE OFFICER
J. 
WARREN 
HUFF 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
M. 
KRAL, JR. 
EXECUTIVE OFFICER
MELISSA 
 
KRAUTH 
EXECUTIVE OFFICER
WILLIAM 
D. 
MCCLELLAN, JR. 
DIRECTOR
KENT 
 
MCGAUGHY 
DIRECTOR
J. 
KENT 
MCGAUGHY, JR. 
DIRECTOR
COLIN 
 
MEYER 
EXECUTIVE OFFICER
COLIN 
J. 
MEYER, M.D. 
EXECUTIVE OFFICER
JACK 
B. 
NIELSEN 
DIRECTOR
EDWARD 
W. 
ROSE 
DIRECTOR
WILLIAM 
E. 
ROSE 
DIRECTOR
CHARLES 
A. 
SANDERS 
DIRECTOR
MANMEET 
S. 
SONI 
EXECUTIVE OFFICER
DENNIS 
 
STONE 
DIRECTOR
MELEAN 
 
VISNICK 
EXECUTIVE OFFICER
JOHN 
 
WALLING 
EXECUTIVE OFFICER
WILLIAM 
CHRISTIAN 
WIGLEY 
EXECUTIVE OFFICER
JASON 
D. 
WILSON 
EXECUTIVE OFFICER
MICHAEL 
D. 
WORTLEY 
EXECUTIVE OFFICER
NANCY 
 
WYSENSKI 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-06-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#